News
1d
MedPage Today on MSNBCG Revaccination Hopes Dim for Tuberculosis PreventionA prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...
Key Highlights of BCG Vaccine Market In 2023, the Asia Pacific region dominated the market, representing over 60.5% of the overall revenue share North America will likely exhibit the fastest growth ...
Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...
The Ministry of Food and Drug Safety rejected GC Biopharma's application for approval of its tuberculosis vaccine (BCG). The possibility of domestic production of the tuberculosis vaccine ...
Getting a shingles vaccine may help with more than the viral infection that causes painful rashes — new research shows it can also lower the risk of heart disease. In a study, published Monday ...
Now that measles, which was declared eliminated from the U.S. in 2000, has re-emerged in this country, here’s something you may be wondering about: whether you should get a measles vaccine booster.
Anktiva plus BCG aims to treat BCG-unresponsive NMIBC with papillary ... with long-term memory is the foundation of our efforts to develop a therapeutic cancer vaccine across multiple tumor types, ...
Meanwhile, the country's top health official, Robert F. Kennedy Jr., is an unswerving anti-vaccine advocate with a long history of spreading dangerous misinformation, which may spur vaccination ...
BCG (Bacillus Calmette - Guerin) vaccine is made from a treated (attenuated) live strain of bacterium derived from Mycobacterium bovis, a bacterium which typically causes tuberculosis (TB ...
A type of herpes virus — the varicella-zoster virus — causes chickenpox in childhood and shingles later in life. Shingles travels along nerves, triggering a distinctive blistering rash and ...
The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research ...
Cretostimogene for CIS-containing BCG unresponsive nonmuscle-invasive bladder cancer showed “best in class durability and tolerability,” according to investigators. Cretostimogene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results